Select Page

VisMederi Holding

Improving human health

VisMederi Group

VisMederi Group operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

In addition, the Group also includes the VisMederi Foundation, which has the purpose of transferring the Group’s research on the territory as well as supporting projects and actions in favour of the developing countries.

The Holding brings together all the strategic and central activities common to all subsidiaries, from administrative, financial and management control services to legal ones; from Quality to Communications, which all play a central role in supporting Research activities.

The success of the VisMederi Group originates largely from solid values and from the human capital here investing its skills and professionalism – highly motivated men and women who share the Company’s mission and the solid roots in a peculiar territory with an international flavour.

Worldwide Business

\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\

the founder

Emanuele

Montomoli

 

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.
His research interests are primarily in the field of influenza vaccines, and in particular in the study of correlates of protection. He is an expert in the development, standardization and validation of assays for antibody detection. He has conducted many clinical and laboratory research studies to evaluate immunogenicity and efficacy of traditional and new influenza vaccines. Recently, he has participated in protocols for the development and evaluation of new molecules as adjuvants. He has also undertook planning and execution of European seroepidemiological studies for emerging infectious diseases in collaboration with WHO Regional Office and eCDC.

In 2012, he was appointed in the Scientific Advisory Board of international Society for Influenza and other Respiratory Viral Diseases (ISIRV).
In 2015, he became Scientific Coordinator for a European IMI (Innovative Medicine Initiative) Project titled “Standardization and development of assays for assessment of influenza vaccine correlates of protection (FLUCOP)” (IMI-JU-10-2013-01, Grant Agreement No 115672).
He has organized the 1st, 2nd and 3rd editions of the Summer School on Influenza in Siena with the support of ISIRV.
Over the years, he has published almost 70 scientific papers and reviews, and written several chapters in textbooks.

In VisMederi, he is in charge with the position of Chief Scientific Officer and not executive President.

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.
His research interests are primarily in the field of influenza vaccines, and in particular in the study of correlates of protection. He is an expert in the development, standardization and validation of assays for antibody detection. He has conducted many clinical and laboratory research studies to evaluate immunogenicity and efficacy of traditional and new influenza vaccines. Recently, he has participated in protocols for the development and evaluation of new molecules as adjuvants. He has also undertook planning and execution of European seroepidemiological studies for emerging infectious diseases in collaboration with WHO Regional Office and eCDC.

In 2012, he was appointed in the Scientific Advisory Board of international Society for Influenza and other Respiratory Viral Diseases (ISIRV).
In 2015, he became Scientific Coordinator for a European IMI (Innovative Medicine Initiative) Project titled “Standardization and development of assays for assessment of influenza vaccine correlates of protection (FLUCOP)” (IMI-JU-10-2013-01, Grant Agreement No 115672).
He has organized the 1st, 2nd and 3rd editions of the Summer School on Influenza in Siena with the support of ISIRV.
Over the years, he has published almost 70 scientific papers and reviews, and written several chapters in textbooks.

In VisMederi, he is in charge with the position of Chief Scientific Officer and not executive President.